Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine
✍ Scribed by K. Zulkowski; R. Kath; R. Semrau; K. Merkle; K. Höffken
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 128 KB
- Volume
- 128
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Brain metastases are diagnosed in 15% of patients with metastatic breast carcinoma. most patients are treated with whole-brain radiotherapy (wbrt) and/or chemotherapy. the information on surgical results is sparse. ## Methods: Among 709 patients with tumors metastatic to the brain
Since most patients with brain metastases from breast cancer have disseminated disease elsewhere and a dismal prognosis when treated by whole brain irradiation alone, we investigated the use of systemic chemotherapy in 66 such patients. Fifty-two percent (34 of 66 patients) demonstrated an objective